8ptl
From Proteopedia
(Difference between revisions)
m (Protected "8ptl" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==human PHOX2B C-terminal domain including the polyA fragment at 278K== | |
- | + | <StructureSection load='8ptl' size='340' side='right'caption='[[8ptl]]' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[8ptl]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8PTL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8PTL FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> | |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8ptl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8ptl OCA], [https://pdbe.org/8ptl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8ptl RCSB], [https://www.ebi.ac.uk/pdbsum/8ptl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8ptl ProSAT]</span></td></tr> |
+ | </table> | ||
+ | == Disease == | ||
+ | [https://www.uniprot.org/uniprot/PHX2B_HUMAN PHX2B_HUMAN] Neuroblastoma;Congenital central hypoventilation syndrome;Hirschsprung disease-ganglioneuroblastoma syndrome;Haddad syndrome. The disease is caused by variants affecting the gene represented in this entry. Disease susceptibility is associated with variants affecting the gene represented in this entry. | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/PHX2B_HUMAN PHX2B_HUMAN] Involved in the development of several major noradrenergic neuron populations, including the locus coeruleus. Transcription factor which could determine a neurotransmitter phenotype in vertebrates. Enhances second-messenger-mediated activation of the dopamine beta-hydrolase and c-fos promoters, and of several enhancers including cAMP-response element and serum-response element. | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Anton R]] | ||
+ | [[Category: Babu M]] | ||
+ | [[Category: Cabrita EJ]] | ||
+ | [[Category: Felix S]] | ||
+ | [[Category: Oroz J]] | ||
+ | [[Category: Pantoja-Uceda D]] | ||
+ | [[Category: Tinnefeld P]] | ||
+ | [[Category: Trevino MA]] | ||
+ | [[Category: Vera AM]] | ||
+ | [[Category: Zweckstetter M]] |
Current revision
human PHOX2B C-terminal domain including the polyA fragment at 278K
|
Categories: Homo sapiens | Large Structures | Anton R | Babu M | Cabrita EJ | Felix S | Oroz J | Pantoja-Uceda D | Tinnefeld P | Trevino MA | Vera AM | Zweckstetter M